临床外科杂志 ›› 2022, Vol. 30 ›› Issue (5): 453-458.doi: 10.3969/j.issn.1005-6483.2022.05.015

• 论著 • 上一篇    下一篇

叉头框蛋白Q1和细胞周期蛋白D1在非小细胞肺癌组织中的表达与临床病理特征及预后的关系

  

  1. 644000 四川省宜宾市第一人民医院胸心外科
  • 收稿日期:2021-06-10 接受日期:2021-06-10 出版日期:2022-05-20 发布日期:2022-06-20

Expression of forkhead box Q1 and CyclinD1 in non-small cell lung cancer and their relationship with clinicopathological features and prognosis

  1. Department of Cardiothoracic Surgery,the First People’s Hospital of Yibin City,Sichuan,Yibin 644000,China
  • Received:2021-06-10 Accepted:2021-06-10 Online:2022-05-20 Published:2022-06-20

摘要: [摘要] 目的 探讨非小细胞肺癌(NSCLC)组织中叉头框蛋白Q1(FOXQ1)和细胞周期蛋白D1(CyclinD1)的表达水平与临床病理特征及预后的关系。方法 选取2014年12月~2017年10月我院诊治的NSCLC病人癌组织标本196例及癌旁组织标本30例,采用免疫组化EnVisio法检测NSCLC组织及癌旁组织中FOXQ1和CyclinD1蛋白表达;分析FOXQ1、CyclinD1的表达与NSCLC病人临床病理参数的关系。采用Spearman相关分析FOXQ1与CyclinD1的相关性;采用Cox比例风险回归模型分析NSCLC病人预后的影响因素;采用Kaplan-Meier生存曲线分析FOXQ1、CyclinD表达与病人预后的关系。结果 NSCLC组织中FOXQ1、CyclinD1蛋白高表达率高于癌旁组织(P<0.05);NSCLC组织中FOXQ1、CyclinDl高表达与病理分化程度、临床分期、淋巴结转移相关(P<0.05);Spearman相关分析显示,NSCLC组织中FOXQ1表达与CyclinD1表达呈正相关(P<0.05);Cox回归分析显示,FOXQ1高表达、CyclinD1高表达、FOXQ1+CyclinD1高表达均是影响NSCLC病人无进展生存期(PFS)和总生存时间(OS)的独立危险因素(P<0.05);Kaplan-Meier分析显示,FOXQ1、CyclinDl两者高表达病人PFS和OS短于其他病人(P<0.05)。结论 FOXQ1、CyclinD1蛋白在NSCLC组织中高表达,两者与疾病的发生、发展及预后密切相关,两者联合检测能更好地判断NSCLC病人的预后。

关键词: 非小细胞肺癌, 叉头框蛋白Q1, 细胞周期蛋白D1, 预后, 临床病理特征

Abstract: [Abstract] Objective To explore the expression levels of FOXQ1 and CyclinD1 in non-small cell lung cancer (NSCLC),and analyze their relationship with clinicopathological features and prognosis. Methods 196 cancer tissue samples and 30 adjacent tissue samples of NSCLC patients treated in our hospital from December 2014 to October 2017 were selected.The expressions of FOXQ1 and cyclinD1 protein in NSCLC tissues and adjacent tissues were detected by EnVisio immunohistochemistry.The expression levels of FOXQ1 and CyclinD1 in NSCLC and their relationship with clinicopathological parameters were analyzed.Spearman correlation was used to analyze the correlation between FOXQ1 and CyclinD1.Cox proportional hazards regression model was used to analyze the prognostic factors of NSCLC patients.Kaplan Meier survival curve was used to analyze the relationship between the expression of FOXQ1 and CyclinD and the prognosis. Results The high expression rates of FOXQ1 and cyclinD1 protein in NSCLC tissues were higher than those in paracancerous tissues (P<0.05).The high expression of FOXQ1 and CyclinDl in NSCLC was correlated with pathological differentiation,clinical stage and lymph node metastasis (P<0.05).Spearman correlation analysis showed that there was a positive correlation between foxq1 expression and CyclinD1 expression in NSCLC (P<0.05).Cox regression analysis showed that high expression of FOXQ1,CyclinD1 and FOXQ1+CyclinD1 were independent risk factors for progression free survival (PFS) and overall survival (OS) of NSCLC patients (P<0.05).Kaplan Meier analysis showed that the cumulative survival rates of PFS and OS in patients with high expression of FOXQ1 and CyclinDl were lower than those in other patients (P<0.05).The cumulative survival rates of PFS and OS in patients with high expression of FOXQ1 and CyclinDl were lower than those in patients with high expression of FOXQ1 and CyclinD1 alone (P<0.05).Conclusion FOXQ1 and CyclinD1 are highly expressed in NSCLC tissues,which are closely related to the occurrence,development and prognosis of the disease.FOXQ1 and cyclinD1 protein are positively correlated,the combined detection of both can better judge the prognosis of NSCLC patients.

Key words: non-small cell lung cancer, forkhead box Q1, CyclinD1, prognosis, clinical pathology features

[1] 李宗富 陈铁良 丁梅 王增辉 陈建利. 快速康复外科对早期胃癌腹腔镜辅助保留幽门胃切除术患者营养状态的影响分析[J]. 临床外科杂志, 2022, 30(5): 433-436.
[2] 阮添 李昌盛 杨泽天 周雪峰 王乐. 内脏胸膜侵犯对术后ⅢA/N2期非小细胞肺癌病人生存的影响:SEER数据库分析[J]. 临床外科杂志, 2022, 30(5): 448-452.
[3] 詹浩东 王荣 李剑. 改良格拉斯哥预后评分联合纤维蛋白原与前白蛋白比值对胸腔镜肺叶切除术治疗肺癌的预后评估价值[J]. 临床外科杂志, 2022, 30(5): 459-462.
[4] 卞春安 田晓奇 林超宇 许里. CRYAB在肺鳞癌中的表达及其临床意义[J]. 临床外科杂志, 2022, 30(5): 486-489.
[5] 杨恒 张军 郭强 林称意 罗卫民 原野 程栋梁 罗湘玉 刘华 郭家龙. 基于多数据库分析HLA-DPB1在肺腺癌中的潜在价值[J]. 临床外科杂志, 2022, 30(4): 339-344.
[6] 金一 王昕仪 杜润森 郑丽华 赵亚恒 杨艳. 乳腺癌组织hsa-mir-337表达降低的临床意义与预后分析[J]. 临床外科杂志, 2022, 30(4): 345-348.
[7] 王鹏远 尚义超 郑铎 尚攀峰 岳中瑾. 肾盂癌与输尿管癌术后预后分析[J]. 临床外科杂志, 2022, 30(4): 368-371.
[8] 李铃睿 宋俊龙 刘汉卿 孔德光 陈创. 甲状腺乳头状癌的基因变异与临床病理特点分析[J]. 临床外科杂志, 2022, 30(3): 222-225.
[9] 卢开进 申江峰 贾卫光. 胸腔镜改良喉返神旁经淋巴结清扫治疗食管癌的疗效及对预后的影响[J]. 临床外科杂志, 2022, 30(3): 257-260.
[10] 沈荐 李敏哲 杜燕夫. 中心型肥胖对腹腔镜远端胃癌D2根治术临床疗效的影响[J]. 临床外科杂志, 2022, 30(3): 261-265.
[11] 李玉柱 夏连杰. 膀胱癌病人癌组织中Dickkopf相关蛋白2的表达及与预后的相关性[J]. 临床外科杂志, 2022, 30(3): 280-283.
[12] 季金涛 康波 苏燕胜. 前列腺特异性膜抗原在前列腺癌组织中的表达与临床病理特征的关系及预后价值[J]. 临床外科杂志, 2022, 30(2): 130-133.
[13] 李云龙 杜正华 张慧敏 解凤妮 李纪鹏. 胃肠胰神经内分泌肿瘤临床治疗及预后分析[J]. 临床外科杂志, 2022, 30(2): 166-170.
[14] 高明朗 邓宇 姚颐 耿庆. 2022年V1版《NCCN非小细胞肺癌临床实践指南》更新解读[J]. 临床外科杂志, 2022, 30(1): 20-22.
[15] 何领 徐鲲 任明 陈晨 郭嵩 朱太阳 陈德轩 高国宇 王高元. 伴桥本甲状腺炎的甲状腺乳头状癌临床病理特征及其手术策略[J]. 临床外科杂志, 2022, 30(1): 40-43.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[2] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[3] 杨钦;张再重;王烈. 空肠间置术在Siewert Ⅱ型食管胃结合部腺癌中的应用[J]. 临床外科杂志, 2016, 24(11): 816 .
[4] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[5] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[6] 林伟箭;洪雪辉;许淑镇;等. 吸引器在腹腔镜胃癌根治术中的应用体会[J]. 临床外科杂志, 2016, 24(11): 824 .
[7] 方军;余阳;许涛;等. 小野寺营养预后指数在胃癌患者预后评估中的价值[J]. 临床外科杂志, 2016, 24(11): 831 .
[8] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[9] 吴超;谢迪;汪全新;等. 胃癌肝转移的临床病理特征及危险因素分析[J]. 临床外科杂志, 2016, 24(11): 839 .
[10] 许州;陈谦学;李明昌;等. 胶质瘤中miR383与其靶向circ_001634相互调控机制及作用研究[J]. 临床外科杂志, 2016, 24(11): 844 .